Bethesda, MD12 Active Studies

Neuroendocrine Tumors Clinical Trials in Bethesda, MD

Find 12 actively recruiting neuroendocrine tumors clinical trials in Bethesda, MD. Connect with local research sites and explore new treatment options.

12
Active Trials
7
Sponsors
27,850
Enrolling

Recruiting Neuroendocrine Tumors Studies in Bethesda

About Neuroendocrine Tumors Clinical Trials in Bethesda

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 12 neuroendocrine tumors clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 27,850 participants. Research is being sponsored by National Human Genome Research Institute (NHGRI), National Eye Institute (NEI), National Institute of Environmental Health Sciences (NIEHS) and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Bethesda — FAQ

Are there neuroendocrine tumors clinical trials in Bethesda?

Yes, there are 12 neuroendocrine tumors clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 12 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated July 13, 2026 from ClinicalTrials.gov